Hatice Terzi

6PUBLICATIONS
144CO-AUTHORS
Molecular targetsTumour immunologyMedical biochemistry - proteins and peptides (incl. medical proteomics)Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 12, 2026
Apigenin as a Multitarget Anticancer Agent: Coordinated Inhibition of EGFR/MAPK and PI3K/Akt Signaling in Hematologic Malignancies.

|May 16, 2025
Evaluation of the Antitumoral Effect of PI3K/AKT/mTOR Pathway Inhibition and Antioxidant Combination on Burkitt Lymphoma Cell Line.

Ibrahim Karaduman, Hatice Terzi, Seyma Tastemur

|Feb 07, 2025
Relationship of Plasma Cell Infiltration Rates with 18F-FDG PET/CT Data and Hematological Parameters in Multiple Myeloma.

Özge Ulaş Babacan, Zekiye Hasbek, Hatice Terzi

|Sep 15, 2021
Clinical Characteristics and Outcomes of COVID-19 in Turkish Patients with Hematological Malignancies

Sinem Civriz Bozdağ, Güldane Cengiz Seval, İpek Yönal Hindilerden

|Jul 23, 2019
A Multi-Center Study on the Efficacy of Eltrombopag in Management of Refractory Chronic Immune Thrombocytopenia: A Real-Life Experience

Demet Çekdemir, Serkan Güvenç, Füsun Özdemirkıran

|Jul 15, 2017
Nodular lymphocyte predominant Hodgkin's lymphoma in daily practice: A multicenter experience.

Aliihsan Gemici, Ismet Aydogdu, Hatice Terzi

Pageof 1

Frequent Collaborators

2 joint publications

Muhit Özcan

2 joint publications

Reyhan Diz Küçükkaya

2 joint publications

Sinan Demircioğlu

2 joint publications

Vildan Özkocaman